The Histoplasma GM EIA offers an in-house assay to assist in reducing the number of misdiagnosed patients.
This test is a commercially available diagnostic kit for the detection of Histoplasma antigen. In-house rapid testing is much more cost effective than send-out testing.1
1) Cáceres DH, Samayoa BE, Medina NG, et al. Multicenter Validation of Commercial Antigenuria Reagents To Diagnose Progressive Disseminated Histoplasmosis in People Living with HIV/AIDS in Two Latin American Countries. J Clin Microbiol. 2018;56(6):e01959-17.
Quantitative Standard Curve Method vs. Culture-Proven Histoplasmosis & Controls1 |
|
---|---|
Sensitivity | Specificity |
98% | 97% |
Semi-Quantitative Calibrator Cut-off Method vs. Culture-Proven Histoplasmosis & Controls1 |
|
---|---|
Sensitivity | Specificity |
95% | 98% |
Histoplasma Galactomannan EIA | 96 tests | HGM201 |
---|